Results: 21
Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Immunophenotype-defined sub-populations are common at diagnosis in childhood B-cell precursor acute lymphoblastic leukemia.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 10, p. 1548, doi. 10.1038/leu.2011.123
- By:
- Publication type:
- Article
A novel ABL1 fusion to the SH2 containing inositol phosphatase-1 (SHIP1) in acute lymphoblastic leukemia (ALL).
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Stable and reproducible engraftment of primary adult and pediatric acute myeloid leukemia in NSG mice.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Notch signaling in mammalian hematopoietic stem cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2.
- Published in:
- 2011
- By:
- Publication type:
- Letter
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Impact of lenalidomide dose on progression-free survival in patients with relapsed or refractory multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
IDH1 and IDH2 mutations in pediatric acute leukemia.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Mutation analysis of TET2, IDH1, IDH2 and ASXL1 in chronic myeloid leukemia.
- Published in:
- 2011
- By:
- Publication type:
- Letter
TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 10, p. 1578, doi. 10.1038/leu.2011.140
- By:
- Publication type:
- Article
The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 10, p. 1533, doi. 10.1038/leu.2011.122
- By:
- Publication type:
- Article
Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 10, p. 1627, doi. 10.1038/leu.2011.131
- By:
- Publication type:
- Article
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles.
- Published in:
- 2011
- By:
- Publication type:
- journal article
An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia.
- Published in:
- 2011
- By:
- Publication type:
- Letter